ClinicalTrials.gg

Neurodevelopmental Disorders clinical trials

The registry lists 352 studies for Neurodevelopmental Disorders across more than 10 countries. 141 are recruiting or about to start. 153 of them are mainly about Neurodevelopmental Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 38 narrower conditions too, such as Attention Deficit Disorder with Hyperactivity: 7,096 studies, 1,641 open.

Get an email when these change. Save the Neurodevelopmental Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
143
Recruiting
100
Active, not recruiting
32
Not yet recruiting
31
Status unknown
29
Enrolling by invitation
10

Phase

Phase 3
17
Phase 2
14
Phase 1
6
Phase 4
3
Early Phase 1
2

Where

United States
98
France
50
Italy
35
Canada
24
Spain
20
United Kingdom
17

What is being tested here

Drugs under test in Neurodevelopmental Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

50studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 100 Neurodevelopmental Disorders studies recruiting now, 20 (20%) set no upper age limit and 76 (76%) stop at 75 or younger. 86 (86%) take children under 18. 5 (5%) are for women only and 1 (1%) for men only; 31 (31%) take healthy volunteers.

Recruiting studies that take each age, of 100
AgeWomenMen
1056 (56%)55 (55%)
1844 (44%)40 (40%)
3039 (39%)35 (35%)
4036 (36%)33 (33%)
5029 (29%)28 (28%)
6525 (25%)24 (24%)
7524 (24%)23 (23%)
8523 (23%)22 (22%)

Across all 352 studies, recruiting or not: 79% stop at 75 or younger and 79% at 65; 86% take children; 5% are for women only and 1% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neurodevelopmental Disorders studies take

Of 148 interventional studies with no phase under Neurodevelopmental Disorders, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase30 mo15–52 · 148 studies—30 mo15–52 · 142 studies
Observational59 mo32–101 · 70 studies—59 mo32–101 · 67 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 352. Browse all 352 → or search them.